The purpose of this study was to report on the occurrence and management of posterior synechiae (PS) in three hyperopic eyes after iris-fixated anterior chamber phakic IOL implantation. This is a case report of a 55-year-old man and a 55-year-old lady who had undergone iris-fixated anterior chamber phakic IOL implantation to correct hyperopic astigmatism (one eye) and hyperopia (both eyes), respectively. The three eyes developed creeping PS and pigment dispersion within 4-6 weeks of surgery. Synechiolysis and pupil stretching in one eye did not work as the synechiae promptly recurred. Definitive management in the form of removal of the phakic implant and phacoemulsification with lens implant was successful in restoring normal vision in all three eyes. Although implantation of phakic intraocular lenses has been reported to be very effective for the correction of moderate to high degrees of ametropia, this complication can occur in hyperopic eyes. Pigment dispersion has been reported in myopic eyes also, but PS seem to be more an issue with hyperopic eyes. Age of the patient may also be a factor. This information is important in the selection and counselling of patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10792-016-0202-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phosphoribosyl pyrophosphate synthetase 1 () associated retinal degeneration: an international study.
Ophthalmic Genet
January 2025
Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.
Introduction: Phosphoribosyl pyrophosphate synthetase 1 () is an X-linked gene critical for nucleotide metabolism. Pathogenic variants cause three overlapping phenotypes: Arts syndrome (severe neurological disease), Charcot-Marie-Tooth type 5 [CMTX5] (peripheral neuropathy), and non-syndromic sensorineural hearing loss (SNHL). Each may be associated with retinal dystrophy.
View Article and Find Full Text PDFStability of refractive outcomes after hyperopic LASIK with and without Mitomycin C application: a randomized controlled trial.
Sci Rep
January 2025
Department of Ophthalmology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University, Moorenstraße 5, 40225, Dusseldorf, Germany.
To assess the efficacy, safety, and stability of refractive outcomes in hyperopic Laser-Assisted in Situ Keratomileusis (LASIK) with and without the application of Mitomycin C (MMC). This randomized, parallel group, controlled multicenter trial included 140 hyperopic eyes. The participants were randomly assigned to two groups: one receiving LASIK with mitomycin C (MMC) (n = 70) and the other receiving LASIK without MMC (n = 70).
View Article and Find Full Text PDFPhysiological change in ganglion cell inner plexiform layer and nerve fibre layer thickness over six years.
Clin Exp Ophthalmol
January 2025
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Background: To evaluate the 6-year physiological rates-of-change in ganglion cell inner plexiform layer (GCIPL) and retinal nerve fibre layer (RNFL) thickness measured with optical coherence tomography.
Methods: We included 2202 out of 2661 subjects from the population-based Singapore Chinese Eye Study who returned for follow-up 6 years after baseline examination (follow-up rate 87.7%).
Comparison of Intraocular Lens Formulas in Patients With Postoperative Refractive Surprise.
Cureus
December 2024
Ophthalmology, University of Washington, Seattle, USA.
Objective: This study investigates the refractive accuracy of eight intraocular lens (IOL) power calculation formulas in patients with postoperative refractive surprise after phacoemulsification. It aims to determine if a different formula could result in better refractive outcomes in these eyes.
Methods And Analysis: We retrospectively reviewed consecutive patients undergoing uncomplicated phacoemulsification as a sole procedure between March 2007 and September 2020 at the University of Washington by glaucoma subspecialists as part of a study investigating cataract surgery in normal eyes.
Comparison of ocular biometry and refractive outcomes using two swept-source optical coherence tomography-based biometers.
PLoS One
December 2024
Department of Ophthalmology, Samsung Medical Center School of Medicine, Sungkyunkwan University, Seoul, Republic of Korea.
Background: To evaluate the ocular biometry agreement and prediction of postoperative refractive outcomes obtained using two swept-source optical coherence tomography (SS-OCT) biometers: Anterion (Heidelberg Engineering, Heidelberg, Germany) and Argos (Alcon, Fort Worth, TX, USA).
Methods: Ambispective analysis was conducted on 105 eyes at the Samsung Medical Center, Seoul, Republic of Korea, between June 2021 and March 2022. Biometric values were assessed using both devices before cataract surgery.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!